Breaux Castleman's most recent trade in Ionis Pharmaceuticals Inc was a trade of 12,000 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on July 1, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals Inc | Breaux B. Castleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 12,000 | 12,000 | - | - | Director Stock Option (right to buy) | |
Ionis Pharmaceuticals Inc | Breaux B. Castleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 5,333 | 5,333 | - | - | Restricted Stock Units | |
Ionis Pharmaceuticals Inc | Breaux B. Castleman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 1,778 | 17,627 (0%) | 0% | 0 | Common Stock | |
Ionis Pharmaceuticals Inc | Breaux B. Castleman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 1,778 | 5,332 | - | - | Restricted Stock Units | |
Ionis Pharmaceuticals Inc | Breaux B. Castleman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 889 | 18,516 (0%) | 0% | 0 | Common Stock | |
Ionis Pharmaceuticals Inc | Breaux B. Castleman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 889 | 1,777 | - | - | Restricted Stock Units | |
Ionis Pharmaceuticals Inc | Breaux B. Castleman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 667 | 19,183 (0%) | 0% | 0 | Common Stock | |
Ionis Pharmaceuticals Inc | Breaux B. Castleman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 667 | 666 | - | - | Restricted Stock Units | |
Ionis Pharmaceuticals Inc | Breaux B. Castleman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 666 | 15,849 (0%) | 0% | 0 | Common Stock | |
Ionis Pharmaceuticals Inc | Breaux B. Castleman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 666 | 0 | - | - | Restricted Stock Units | |
Ionis Pharmaceuticals Inc | Breaux B. Castleman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2020 | 10,000 | 12,500 | - | - | Director Stock Option (right to buy) | |
Ionis Pharmaceuticals Inc | Breaux B. Castleman | Director | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 25 Jun 2020 | 10,000 | 15,183 (0%) | 0% | 60 | 600,000 | Common Stock |
Ionis Pharmaceuticals Inc | Breaux B. Castleman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 25 Jun 2020 | 10,000 | 25,183 (0%) | 0% | 26.7 | 266,600 | Common Stock |